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As the primary organ of movement, skeletal muscle requires flexible fuel selection 
to support varying levels of physical activity. For instance, at low levels of activity 
and during rest, lipids are the primary source of fuel, while carbohydrates are 
utilized for higher levels of activity. Physical activity is essential for optimal skeletal 
muscle health and function, and lack of physical activity is associated with various 
metabolic impairments, such as metabolic inflexibility, a state where skeletal 
muscle loses efficiency when transitioning between fuel sources. Over time, 
metabolic inflexibility increases the risk of developing various metabolic 
comorbidities, such as obesity, diabetes, and heart disease, among others. 
Metabolic inflexibility can be ameliorated with physical activity and increasing 
physical activity, however various conditions may impair skeletal muscle and 
increase the likelihood of inactivity. Orthopaedic injury is an example of a condition 
that has been shown to reduce physical activity, both acutely and chronically, 
increasing the risk of metabolic inflexibility and metabolic disorder. Volumetric 
muscle loss (VML) injury, in which muscle is abruptly lost through traumatic or 
surgical events, is one such orthopaedic trauma. It is likely that reductions in 
physical activity and whole-body metabolic impairments occur following VML, 
however, physical activity and whole-body metabolic outcomes are currently not 
characterized in the literature. To address this lack of knowledge, a study was 
designed to evaluate physical activity and whole-body metabolic function at 4 and 
8 weeks post-VML injury. The principal finding was that metabolic inflexibility 
developed independently of changes in physical activity levels following VML injury 
and that underlying pathophysiologic changes to the muscle may contribute to 
maladaptive changes at the whole-body level. These findings support that VML 
injury may increase the risk of metabolic comorbidities, and that future efforts may 
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Basic Skeletal Muscle Structure and Function 
Skeletal muscle makes up approximately 40% of the mass of the human body 
in lean individuals and plays a major role in movement and metabolism [1]. The 
primary function of skeletal muscle is to produce force, allowing the human body 
to interact with the outside world. Importantly, skeletal muscle requires energy to 
function, which necessitates coordination between multiple systems, including the 
digestive and circulatory systems, to deliver energy-yielding substrates and 
remove metabolic wastes. Energy utilization in skeletal muscle also generates 
heat, establishing an additional important role of skeletal muscle in 
thermoregulation. Knowledge of skeletal muscle has developed over millennia, 
with an initial focus on basic anatomy and function. 
Understanding of human anatomy has continually improved since the times of 
Galen, DaVinci, and Henry Gray, and a greater understanding of structure leads 
to a better understanding of function. Skeletal muscles are connected to bones by 
tendons forming a series-elastic component. The point of attachment that does not 
move during contraction is the origin, and the point of attachment that moves 
during contraction is the insertion. Typically, the origin is proximal, and the insertion 
is distal. Under direction from the nervous system, skeletal muscles contract and 
apply force on bone within a line of force from insertion to origin. Skeletal muscles 
control movement through contraction, allowing the origin and insertion points to 
move closer together, farther apart, or remain at a constant distance. Multiple 
skeletal muscles typically contract in conjunction, generating movement and 
stability in multiple planes of motion. Dynamic movement requires coordinated 
efforts between agonist and antagonist muscles, where agonistic muscles cause 
a movement through their activation while antagonistic muscles inhibit a 
movement. Additionally, skeletal muscle contraction is essential for breathing, 
vision, speech, postural support, and heat production. 
To perform various functions, skeletal muscles have a specific anatomical 
arrangement. A layer of connective tissue called epimysium sheaths skeletal 




fascicles that are covered by connective tissue layer, the perimysium. Within each 
fascicle are multiple skeletal muscle cells which are surrounded by the connective 
tissue, the endomysium. Skeletal muscle cells are referred to as muscle fibers (or 
myofibers) due to their long, threadlike appearance and will be referred to as such 
henceforth. Skeletal muscle fibers are long and tubular, with diameters that range 
in the tens to hundreds of microns, and lengths up to tens of centimeters depending 
on the organism [2,3]. Muscle fibers are surrounded by the sarcolemma, a 
phospholipid bilayer with electroconductive properties. Incorporated within and 
around the sarcolemma is the extracellular matrix (ECM), made up largely of 
collagens and proteoglycans [4]. The ECM is important for both structure and 
function, contributing to force generation and cell signaling [4]. 
Deep to the ECM are skeletal muscle fibers, the main cells of contraction. 
Skeletal muscle fibers are composed of highly organized functional units called 
sarcomeres, which are aligned in series longitudinally and give the muscle a 
striated appearance. Sarcomeres are made up of the contractile proteins (i.e., 
myosin and actin), structural proteins (e.g., titin and actinin), and regulatory 
proteins (e.g., troponin and tropomyosin) [5]. In the presence of ionic calcium and 
at the expense of energy in the form of adenosine triphosphate (ATP), myosin 
reversibly binds with actin, forming a cross-bridge. Myosin uses energy and 
performs a power stroke, pulling actin and generating force towards the midline, 
then myosin detaches, resets, binds to a new actin, and performs another power 
stroke [5]. This cycle, termed the cross-bridge cycle, repeats and occurs along the 
entire length of skeletal muscle fibers and throughout the entire muscle, resulting 
in whole muscle contraction and force generation. Cross-bridge cycling of myosin 
on actin allows sarcomeres to shorten (isotonic contraction), lengthen (eccentric 
contraction), or remain the same length (isometric contraction) in response to an 





Key Supporting Cells and Organelles 
All tissues in the body undergo development, growth, and repair which is 
typically accomplished by mitosis (hyperplasia) or cell growth (hypertrophy) of 
existing cells, and differentiation of stem cells. However, mature skeletal muscle in 
humans is post-mitotic; therefore, muscle fiber turnover rate is approximately zero 
during normal maintenance [7]. Instead of undergoing mitosis, skeletal muscle 
fibers are equipped with up to hundreds of nuclei per myofiber [8] that provide the 
transcriptional information to replace and maintain fiber components. Nuclei in a 
skeletal muscle fiber are dispersed throughout the cell, and each nuclei regulates 
gene expression in its own localized cytoplasmic region of the cell, termed the 
myonuclear domain [3,9]. In response to various stimuli, nuclei number and activity 
can be altered, allowing the muscle fiber to dynamically change its metabolic 
properties [9]. Total transcriptional and translational trends in a skeletal muscle 
fiber are reflections of the coordinated activity of all of the myonuclear domains 
within the cell. Therefore, if muscle growth is to occur, it must be achieved by 
modulating the activity or number of myonuclear domains. 
 
Stem and Pericyte Cells 
In response to skeletal muscle injury, muscle fibers acquire new nuclei via the 
fusion of satellite cells, which are undifferentiated, local, myogenic progenitor cells 
[2]. Satellite cells are separate from the muscle fiber and located between the basal 
lamina and the sarcolemma [2], and remain in a quiescent state until activated by 
myogenic regulatory factors [10]. While mature skeletal muscle cells are post-
mitotic and largely incapable of division, satellite cells are capable of dividing and 
thus capable of providing new nuclei to muscle fibers. Satellite cells either divide 
symmetrically, generating two new stem cells to expand the satellite cell pool, or 
asymmetrically, generating one stem cell to maintain the satellite cell pool and one 
myogenic cell that will terminally differentiate [11]. 
Maintaining a pool of satellite cells is critical to allowing skeletal muscle to 




myonuclear domain by satellite cell mediated nuclear addition increases the 
capacity for protein synthesis, allowing muscle fibers to increase in size and 
maintain size increases. In an experimental setting, skeletal muscle growth can 
occur independent of myonuclear addition [12], but ultimately, significant muscle 
growth and maintenance of muscle growth in vivo requires expansion of the 
myonuclear domain by adding nuclei to the muscle fiber, typically utilizing satellite 
cells [13,14]. 
Satellite cells are required for skeletal muscle regeneration, however other cells 
are capable of contributing nuclei under certain circumstances. Throughout the 
body, there are cells that can fulfill multiple roles, a characteristic that is essential 
for growth, development, and maintenance of tissues. For example, pericytes are 
cells that are capable of differentiating into adipocytes, chondrocytes, osteocytes, 
phagocytes, granulocytes, and myocytes depending on their environment [15,16]. 
Pericytes are found ubiquitously throughout the human body, colocalized with 
microvasculature. While the most understood role of pericytes is in controlling 
angiogenesis, many different roles of pericytes have been identified. In recent 
decades, pericytes have been implicated in regulating a variety of physiologic 
functions, such as: blood flow, blood vessel permeability, innate immune response, 
and collagen deposition, among others depending on external stimulus [15]. 
The multipotent differentiation potential of pericytes is dependent upon their 
environment. In an experiment conducted by König et al., pericytes that were 
isolated from murine adipose tissue and seeded on an artificial bone scaffold 
differentiated into osteoblasts, promoting bone union following a surgically induced 
fracture [17]. In skeletal muscle, pericytes fulfill their primary function in controlling 
angiogenesis, but also exhibit myogenic potential. Dellavalle and colleagues 
traced the lineage and differentiation of pericytes and found that they are capable 
of contributing to the satellite cell pool and subsequently contributing to growth and 
regeneration of skeletal muscle [18]. All in all, pericytes are a key cell that lends to 






Postnatal skeletal muscle growth in mammals is primarily accomplished 
through muscle hypertrophy [19]. While expanding myonuclear domains is 
necessary for muscle growth, it is ultimately the upregulation of ribosomes that 
facilitates muscle hypertrophy. Ribosomes are the key organelles of protein 
synthesis throughout the body, including in skeletal muscle. They generate various 
proteins within muscle fibers by translating mRNA that originates from the nuclei 
within the fiber. After a growth-promoting stimulus such as from resistance 
exercise, factors like the mammalian target of rapamycin (mTOR) are upregulated, 
promoting ribosomal biogenesis [19]. By increasing the total number of ribosomes, 
translational capacity increases, allowing the muscle fiber to expand in size. Just 
as ribosomes are a key organelle of protein synthesis, mitochondria are key 
organelles of energy metabolism. 
Mitochondria are found within nearly all cells in the body, including skeletal 
muscle. Initially of bacterial origin, mitochondria have evolved in a symbiotic 
manner with eukaryotes [20], contributing to and performing many essential 
functions throughout the body. The major and most well-known role of 
mitochondria is in oxidative metabolism, where glucose is completely oxidized and 
broken down to generate energy through aerobic respiration, using a process 
known as the Krebs cycle (also known as the citric acid cycle or tricarboxylic acid 
cycle). Importantly, enzymes for the Krebs cycle are only found within the 
mitochondria, therefore aerobic respiration occurs exclusively in mitochondria. 
Additionally, mitochondria are involved with regulating cell proliferation, apoptosis, 
redox balance, intracellular calcium, heat production, among other functions [21].  
To perform their various functions, mitochondria are regulated and arranged in 
a highly controlled manner. In skeletal muscle, mitochondria form a highly 
organized and dynamic matrix that adjusts based on the metabolic needs of the 
muscle. Depending on stimuli from signaling molecules, such as peroxisome 
proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), mitochondria 




need by altering quantity and quality of mitochondria [22,23]. For example, 
endurance exercise increases expression of PGC-1α, which consequently 
promotes mitochondrial biogenesis, expanding the mitochondrial network [24]. 
Expanding the mitochondrial network within skeletal muscle in such a way 
improves the capability of the muscle to utilize glucose and fatty acids as energy-
yielding substrates, thus improving whole muscle metabolic capacity. 
While skeletal muscles are similar in their general structure and function, 
variations between key cells and organelles within muscle fibers result in 
differences in functional characteristics of the overall muscle. These variations in 
characteristics allow different muscles to be categorized by their phenotypic 
qualities, which will be discussed in the subsequent section. 
 
Characterization of Skeletal Muscle 
Evidence has existed for over half a century that motor neurons drive skeletal 
muscle fiber characteristics. In a key study, when Buller and colleagues severed 
the nerves from feline soleus muscles and cross innervated the soleus muscle with 
nerves from the flexor digitorum longus muscles, the soleus took on properties that 
resembled the flexor digitorum longus. The reverse occurred in the flexor digitorum 
longus muscle, which expressed characteristics of the soleus muscle [25]. Burke 
and Edgarton expanded on the principle that the motor neuron derives fiber type 
and classified motor units based on muscle fiber contractile speed (fast or slow 
twitch) and fatigue resilience of the motor unit [26]. Collectively, motor units are 
characterized as slow-twitch fatigue resistant (Type S), fast-twitch fatigue resistant 
(Type FR), fast-twitch fatigue intermediate (Type FInt), and fast-twitch fatigable 








Characteristics of Skeletal Muscle Fiber Types 
Muscle fibers within a specific motor unit express isoforms of myosin heavy 
chain (MyHC) that reflect the functional properties of the associated muscle fiber. 
For example, a skeletal muscle fiber within a Type S motor unit contracts slowly, 
therefore, it will express MyHCslow, a form of myosin that has slower contractile 
speed. Muscles fibers within Type FR motor units contract faster than those of 
Type S motor units, and express MyHC2A. Type FInt motor unit muscle fibers 
express MyHC2x, allowing contractile speeds greater than Type S and FR motor 
units. Lastly, muscle fibers of Type FF motor unit express MyHC2b, which allows 
contractions slightly faster than all other muscle fiber types. Muscle fibers are 
commonly typed by MyHC isoform expression, where fibers that express primarily 
MyHCslow are classified as type I, MyHC2A are type IIa, MyHC2x are type IIx, and 
MyHC2b are type IIb, which are notably only found in rodents [27]. While many 
fibers express single MyHC isoforms, co-expression of muscle fiber types occurs. 
For example, in a study by Bottinelli et al., co-expression of fast myosin isoforms 
occurred in 50% of plantaris fibers and 30% of tibialis anterior fibers in rats [28], 
Table 1. Muscle Fiber Characteristics 








Muscle fiber type Type I Type IIa Type IIx Type IIb 
Innervation ratio Low Moderate Moderate High 
Myosin heavy chain 
(MyHC) isoform 
MyHCslow MyHC2A MyHC2x MyHC2b 
Muscle fiber cross 
section diameter 
Small Intermediate Large Very Large 
Contraction speed Slow 
Moderately 
Fast 
Fast Very Fast 
Fatigue resistance High Fairly High Intermediate Low 
Capillary supply High Intermediate Low Low 
Mitochondrial 
content 
High High Intermediate Low 
Glycolytic enzyme 
content 
Low Intermediate High High 




and Billeter et al. observed hybridization of type IIa and IIb fibers, and various 
hybridizations of type I muscle fibers [29]. Hybridization is more likely during 
embryonic development and during pathological states, and often involves types 
I/IIa, and IIx/IIb [30]. 
When considering muscle fiber classification, it is also important to understand 
how metabolism varies between various muscle fiber types. In general, oxidative 
metabolism is utilized for long term energy generation, whereas glycolytic 
metabolism is utilized for fast contractile activity [26]. As a slow contracting and 
fatigue resistant muscle fiber type, type I muscle fibers rely primarily on oxidative 
metabolism. Type IIa muscle fibers have faster contractile activity than type I and 
are somewhat fatigue resistant and thus utilize a combination of oxidative and 
glycolytic metabolism. As a fast twitch and fatigue intermediate fiber, type 2x fibers 
primarily utilize glycolytic metabolism, but maintain some capability for oxidative 
metabolism. As the fastest contracting muscle fiber type, type IIb fibers rely almost 
entirely on glycolytic metabolism. 
 
Whole Skeletal Muscle 
Characteristics of whole skeletal muscle are determined by the overall 
composition of muscle fibers in that muscle. In humans, a muscle that is fatigue 
resistance (i.e., predominately slow-twitch) is typically composed of a high 
proportion of type I muscle fibers whereas muscles that are highly fatigable have 
a higher proportion of type II muscle fibers [31]. For example, muscles that are 
used throughout the day for walking and posture, such as the soleus muscle, are 
composed primarily type I fibers [32]. In contrast, muscles such as the vastus 
lateralis muscle are used to generate large force during a jump or squat, and have 
a higher proportion of type II fibers [33]. While some muscles may have a higher 
proportion of specific fiber types, it is important to note that most muscles have a 





Skeletal Muscle Contraction and Activation 
The somatic branch of the nervous system voluntarily controls skeletal 
muscles. Regions of the brain including the cerebrum and cerebellum send signals 
to upper motor neurons (contained in the brain and brainstem), which relay signals 
to the lower motor neurons [34]. Lower motor neurons that innervate skeletal 
muscles are alpha motor neurons. Axons of alpha motor neurons terminate on 
skeletal muscle fibers at the motor end plate, a specialized synaptic region on the 
skeletal muscle fiber. The connection between an alpha motor neuron and the 
skeletal muscle fiber it innervates is the neuromuscular junction. 
Individual muscle fibers are innervated by a single motor neuron at the 
neuromuscular junction, but a single motor neuron may form a unit with less than 
ten or up to thousands of muscle fibers [35,36]. The motor neuron and all muscle 
fibers it innervates is called a motor unit. All muscle fibers in a motor unit will exhibit 
qualities as dictated by the type of motor neuron, as previously discussed. The 
variance in fiber number per motor unit is the innervation ratio; a motor neuron with 
a large innervation ratio innervates more muscle fibers than a motor neuron with a 
smaller innervation ratio [37–39]. Motor units with small innervation ratios are 
utilized for movements that require finer control (e.g., writing or eye movement) 
whereas motor units with large innervation ratios are utilized for gross movements 
(e.g., knee extension or elbow flexion). Whole muscle contraction is a net result of 
coordinated motor unit activity. Motor units are recruited as needed by the size 
principle [40], starting with smaller type S motor units for weaker, highly controlled, 
and sustainable contractions, followed with larger type FF motor units as the need 
for force generation increases. 
 
Excitation Contraction Coupling 
The coupling of excitation and contraction in skeletal muscle results from a 
series of specific electrochemical events. When a motor neuron is stimulated to 
threshold, an action potential is transmitted from the motor neuron to the motor 




initiates action potentials bidirectionally down the muscle fiber, eventually reaching 
a structure called the transverse tubule (t-tubule). The t-tubule is a specialized 
portion of the sarcolemma that allows action potentials to go deep within the 
muscle, initiating calcium release from the adjacently located sarcoplasmic 
reticulum [41]. Calcium is very concentrated within the sarcoplasmic reticulum and 
once release is initiated, calcium travels down its concentration gradient and floods 
the sarcoplasm of the muscle fiber, initiating subsequent stages of muscle 
contraction. 
Calcium that is released from the sarcoplasmic reticulum binds to troponin, a 
regulatory protein that associates with actin and tropomyosin [41]. Calcium-bound-
troponin moves tropomyosin to expose the myosin-binding site on actin. Once the 
myosin binding site is exposed and providing there is adequate ATP, myosin is 
free to bind with actin and perform a power stroke and force generation of myosin 
on actin [41]. Calcium ATPase pumps (SERCA) located on the sarcoplasmic 
reticulum transport calcium from the sarcoplasm to the sarcoplasmic reticulum, 
preventing a cytotoxic response and prolonged contraction of the muscle fiber. 
Relaxation of the muscle fiber follows once intracellular calcium concentrations are 
sufficiently reduced by SERCA-mediated removal. 
 
Skeletal Muscle Metabolism 
Normally, skeletal muscle maintains a homeostatic balance of protein 
catabolism and anabolism, both of which require energy [42]. In general, muscle 
hypertrophy is a state where anabolism is greater than catabolism, and atrophy is 
a state where catabolism outpaces anabolism. Protein homeostasis is dynamic 
and complicated and fluctuates depending on various factors related to energy 
intake and stimulus from movement. For example, during exercise, muscle 
catabolism is greater than anabolism, resulting in the breakdown of skeletal muscle 
[43]. However, stimulus from exercise subsequently promotes protein anabolism, 
which either rebuilds the muscle to its original state, or results in hypertrophy 




carbohydrates, and lipids for energy. Amino acids from proteins are essential for 
building and maintaining muscle, however amino acids are used primarily as 
material for building proteins rather than as energy substrates [44]. Therefore, 
glucose and lipids are the main energy-yielding molecules in skeletal muscle. 
In skeletal muscle, glucose is a central molecule in both glycolytic and oxidative 
metabolism. Glucose is transported into the muscle from the blood and is either 
used immediately for generating energy in the form of ATP or is stored as glycogen 
(or eventually fat) for future use [45]. The fate of glucose is determined by the 
current state of the muscle. At rest, glucose is primarily stored, since there is no 
immediate need to generate large amounts of energy. During exercise, glucose is 
used both from local glycogen stores and from the blood, however glucose enters 
the muscle utilizing a different transporter during exercise compared to at rest. 
Resting skeletal muscle uses glucose transporter 1 (GLUT1) to transport glucose 
across the membrane in a process that is mediated by insulin signaling [45]. During 
exercise, glucose transporter 4 (GLUT4) is the primary glucose transporter in 
skeletal muscle and is translocated to the sarcolemma from intracellular vesicles, 
dramatically increasing glucose uptake capacity [45]. It is believed that contraction 
is the primary driver of GLUT4 translocation, however the mechanism is not clearly 
understood. It is theorized that depolarizing calcium plays a large role in GLUT4 
translocation, possibly through mediating activation of the SNARE complex, a 
group of proteins involved in vesicle transport [46]. Mobilization of GLUT4 in this 
manner is also dependent on the actin cytoskeleton, which is located right beneath 
the sarcolemma. It is through coordination of markers and receptors on the actin 
cytoskeleton and the vesicles containing GLUT4 that GLUT4 is translocated to the 
proper location. Therefore, it is essential that muscle membrane integrity is 
maintained, and perturbations to membrane structure and contractile function—as 
during injury, disease, and illness—may impair glucose transport. 
Once glucose has entered a muscle cell, glycolysis may begin. During 
glycolysis, glucose is cleaved to liberate energy and produce pyruvate, and 




term, rapid energy production since the energy produced per glucose molecule is 
low, and lactic acid build up is toxic [47]. Alternatively, after pyruvate is produced 
from glycolysis it can be converted into acetyl-CoA and transported into 
mitochondria. Once inside of mitochondria, acetyl-CoA can enter the Krebs cycle, 
a process where acetyl-CoA undergoes various enzymatic conversions, producing 
energy-yielding intermediates (e.g., NADH and FADH2) and carbon dioxide [48]. 
Energy-yielding intermediates from the Krebs cycle are then utilized in the electron 
transport chain (ETC), which is a complex of proteins located in the mitochondria 
where NADH and FADH2 are used in conjunction with oxygen to produce ATP and 
water [48]. In sum, the Krebs cycle and ETC comprise oxidative metabolism, where 
all of the carbon molecules in glucose are completely oxidized for the purpose of 
ATP generation. Oxidative metabolism produces much more ATP per glucose 
molecule, but is a slower process than glycolysis, so it is much better suited for 
providing energy long term. 
In many respects, lipids in muscle metabolism parallels glucose utilization, 
however there are some key differences. Lipids contain long carbon chains that 
can be cleaved off and converted to many acetyl-CoA molecules for use in the 
Krebs cycle. The carbon chains in lipids vary in length, but generally have many 
more carbons than a glucose molecule. Therefore, fats are an efficient way to store 
energy and can produce substantially more energy per molecule than glucose. 
Similar to glucose, lipids are transported from the blood to the inside of the muscle 
fiber where eventually carbons are cleaved for use in the Krebs cycle and ETC. If 
muscle energy balance is positive (i.e., there is sufficient available energy from 
glucose), or when the muscle is at rest, lipids are stored within the muscle fiber as 
intra-myocellular lipids rather than oxidized [49]. Lipids that are stored in the 
muscle cell can be beneficial, as they serve as a local energy store. This is 
apparent in endurance athletes, who have more lipid droplets in their muscles than 
untrained individuals [49]. Lipid dynamics are challenging to study since rodents 
do not store lipids within their muscles as readily as humans do, however, 




skeletal muscle. Perhaps most notably, excess lipids can result in lipotoxicity, 
where lipid derivatives impair regular cellular processes [49]. Lipotoxicity has been 
coined as the primary cause of insulin resistance and subsequent development of 
type 2 diabetes and has been implicated as a factor that contributes to worsening 
sarcopenia, impaired mitochondrial quality, and reduced GLUT4 translocation. 
 
Skeletal Muscle Damage and Repair 
Skeletal muscle is capable of completely repairing itself following a variety of 
injuries. The repair process includes removing damaged tissue, repairing 
damaged fibers, and the accretion of new nuclei in fibers that have lost nuclei as 
a result of damage. After a muscle is injured, neutrophils infiltrate the cite of injury, 
begin clearing debris and any foreign material from the site of injury, and release 
chemoattractant factors [50]. Soon after, macrophages are recruited and 
accumulate. Initially, M1 macrophages promote further inflammation and 
phagocytosis [51]. Once M1 macrophage activity begins to decline, M2 
macrophages take over and secrete anti-inflammatory cytokines and signaling 
factors that promote tissue regeneration [51]. A key aspect of skeletal muscle 
regeneration is the activation and proliferation of satellite cells. When activated, 
satellite cells rapidly divide and subsequently give rise to myogenic progenitors 
[52]. Some of the myogenic progenitors will differentiate and form myofibers to 
regenerate damaged muscle fibers, while the remaining progenitors repopulate the 
satellite cell pool [52]. The muscle is considered regenerated once all damaged 
muscle fibers are repaired and the muscle’s ability to generate force is restored, 
allowing functionality equal to the pre-injured state. However, complete and 
successful regeneration does not always occur, such as the cases when 
volumetric muscle loss (VML) injury occurs. To better understand the complicated 
aspects of regeneration in skeletal muscle, it is prudent to consider various modes 





Toxin and Burn Injury 
One model of skeletal muscle injury and recovery is toxin injury [53]. 
Essentially, various myopathic toxins, such as notexin, cardiotoxin, or α-
bungarotoxin are injected, damaging the muscle and other surrounding tissue, 
then regeneration is studied over time [54]. Notexin is a venom that destroys the 
sarcolemma of muscle fibers, resulting in a toxic calcium influx and subsequent 
necrosis [55]. Another commonly used venom, cardiotoxin, similarly targets 
plasma membranes and results in calcium induced necrosis. Rather than by direct 
degradation of membranes, cardiotoxins form pores in membranes, resulting in a 
toxic influx of calcium [56]. Notexin and cardiotoxin injury results in substantial 
damage to skeletal muscle, but complete regeneration and restoration of function 
is possible within approximately four weeks [55,57]. Other toxins may result in 
permanent damage, α-bungarotoxin targets and destroys receptors for acetyl 
choline, irreversibly preventing end plate potentials from occurring [58]. While the 
contractile proteins are not damaged from α-bungarotoxin, functionality of the 
muscle is severely impeded due to uncoupling excitation and contraction. 
Toxin injury is a valuable example of an often-used injury model to evaluate 
recovery, or lack of recovery, of skeletal muscle, however there are various other 
injury and disease states that add layers of complexity to studying and treating 
skeletal muscle injury. Thermal injuries are an example of an acute injury to 
skeletal muscle. Burns from fire, scalding, or alternative heat sources can cause 
both superficial and deep damage to tissues, resulting in various structural and 
metabolic perturbations. If a burn is severe enough to damage skeletal muscle, the 
effected tissues will have an instantaneous local and systemic response. Initially, 
pro-inflammatory cytokines are released, and the organism enters a state of shock, 
where metabolic rate is slowed, heart rate decreases, and cardiac output is 
reduced [59]. After a few days, a hypermetabolic state is initiated as the organism 
is flooded with endogenous catecholamines and corticosteroids, resulting in a 




Importantly, the more severe the burn, the greater the metabolic disturbance after 
the burn [60,61]. 
Though a burn injury occurs acutely, there are various chronic consequences. 
For example, the robust inflammatory response may take up to half a year to abate, 
and the hypermetabolic response may never return to a preinjury state [59]. The 
aspects driving this hypermetabolic state are largely related to the energy expense 
of healing, as well as a conversion of skeletal muscle to a thermogenic phenotype. 
In a murine burn experiment conducted by Porter et al., experimenters found that 
skeletal muscle experiences an uncoupling of mitochondrial function following burn 
injury [62]. In other words, oxidative metabolism was severely impaired while 
thermogenesis was promoted. Interestingly, muscles that were both local and 
distal to the site of the burn experienced mitochondrial uncoupling, albeit with a 
less extreme response distally. Traumatic injury often has system wide 
impairments, and burn injury aligns with that trend. The post-burn environment 
promotes full body catabolism, protein degradation, insulin resistance, muscle 
wasting, and multi-organ dysfunction [59]. Preserving skeletal muscle through 
exercise (e.g., rehabilitation), hormone supplementation, and dietary 
supplementation, has been found to improve morbidity and mortality in burn 
victims, supporting that skeletal muscle is a key player in the health and function 
following burn injury [63]. 
 
Denervation 
When a skeletal muscle loses neural connections, whether by severing of 
nerves or destruction of neuromuscular junctions, the muscle fiber is considered 
denervated. Depending on the severity of the injury, a whole skeletal muscle may 
be completely denervated or partially denervated. With denervation comes 
corresponding functional loss. In other words, if a skeletal muscle is completely 
denervated it will lose all endogenous ability to generate force, while if some neural 
connections are maintained, some capacity for force generation will remain. Due 




inevitable in denervated skeletal muscle. Significant atrophy is observable within 
days following denervation and continues to worsen over time, with some muscles 
atrophying to less than half of their original size [64,65]. 
Many aspects of muscle metabolism are altered by denervation beyond 
atrophy. Notably, skeletal muscles that have lost innervation lose glycolytic muscle 
fibers and shift towards a more oxidative phenotype [64]. Despite the selective 
preservation of oxidative muscle, mitochondria are dysregulated following 
denervation, leading to impaired oxidative metabolism. Specifically, mitochondrial 
fraction by muscle mass decreases, apoptotic signaling increases, reactive oxidant 
species (ROS) production increases, ATP production is reduced, and the 
mitochondrial fission and fusion is disrupted [66–68]. All of these factors contribute 




When critical illnesses occur, such as secondary to heart failure, cancer, 
respiratory distress, and organ failure, the body enters a state of survival. In such 
a state, maintaining the muscular system is not a priority. In fact, the muscular 
system tends to waste, as was observed in a prospective study conducted by 
Lodeserto and Yende, where critically ill patients were found to lose ~10% of their 
rectus femoris size in 10 days [70]. Besides sheer size loss, critically ill patients 
had reduced muscle fiber cross sectional area and reduced protein synthesis, and 
54% of patients had myofibers necrosis. The phenomenon where muscle is rapidly 
lost during critical illness has been under investigation for over a century. In the 
last 50 years, Bolten et. al coined the term “critical illness polyneuropathy”, linking 
the muscle wasting to sepsis [71]. Typically, critical illness polyneuropathy is paired 
with myopathy, both of which affect more than one third of critically ill patients [72]. 
While maintaining skeletal muscle may not be critical in acute moments when life 
is in the balance, it does play a substantial role in long-term survival, health, and 




While not all critical illnesses effect skeletal muscle in exactly the same ways, 
there are a few common consequences following critical illness. In general, the 
body enters a state that promotes catabolism, resulting in significant weight loss 
and atrophy of skeletal muscle tissue, especially type II fibers [72–74]. During 
critical illnesses secondary to heart failure and cancer, cachexia can occur, a 
multifactorial syndrome characterized by progressive full-body wasting [75]. 
Cachexia is severe and often irreversible, even with sufficient dietary intake and 
supplementation, and since it is poorly understood, the recommended way to treat 
cachexia is to treat the primary illness. This is problematic because critical 
illnesses are often difficult to treat and requires long term, individualized care. 
Further, metabolism during critical illness is dysregulated beyond heightened 
catabolism. Mitochondria are especially sensitive to critical illness, and 
dysregulation of the mitochondrial network is expected to contribute to other 
aspects of critical illness that affect skeletal muscle, such as cachexia, increased 
oxidative stress, and lower oxidative capacity [72,76]. 
Whatever the etiology of critical illness, skeletal muscle is typically negatively 
affected. Whether directly by the pathophysiology of the condition, or indirectly by 
inducing low mobility and physical activity, it is important to consider skeletal 
muscle health when establishing an effective treatment plan. In the past few 
decades, evidence suggests that early mobilization improves patient outcomes 
following critical illness, while lack of mobilization results in prolonged recovery and 
worse outcomes [72,77]. 
 
Muscular Dystrophy 
Muscular dystrophies are genetic disorders where mutations in structural 
proteins, such as dystrophin or titin, can result in muscle and metabolic 
dysfunction, and early death [78]. There are more than 30 types of muscular 
dystrophy with different pathologies depending on what proteins are affected. 
Regardless of the type of dystrophy, the affected muscles are of lower structural 




[79]. Dystrophic muscles attempt to repair and replace damaged or lost muscle 
fibers, however the endogenous repair is insufficient and further degeneration is 
expected. Indeed, a hallmark of muscular dystrophy is a cycle of degeneration and 
regeneration, which typically worsens as the disease progresses [79]. With 
degeneration and regeneration cyclical, robust inflammation is typical. 
Unfortunately, inflammation is also a driver of further degeneration, resulting in 
even further inflammation [79]. The inflammatory and degenerative environment 
that is established in muscular dystrophy is not favorable for muscle regeneration 
and instead promotes the development of fibrosis, another hallmark of muscular 
dystrophy [78,80]. Problems with regulating connective tissue (e.g. fibrosis) is a 
central issue in muscular dystrophy, which often is linked to problems at the muscle 
membrane. 
Disruptions in muscle membrane function and integrity, as observed in 
muscular dystrophies, can have severe consequences for whole body metabolism. 
One critical example is aberrant glucose metabolism. Dystrophic muscle, 
especially in dystrophies that specifically effect membrane transport proteins, 
becomes increasingly insulin resistant over time [79]. As muscle continues to break 
down and fibrosis builds up, the decrease in total amount of muscle tissue involved 
in insulin-mediated glucose metabolism often results in increased prevalence of 
diabetes and obesity among dystrophic patients [79]. Such impairments have 
cyclical consequences, where dystrophy promotes and exacerbates diabetes, and 
diabetes further impairs the body’s ability to regenerate and balance metabolic 
needs. Recent works have targeted collagens that may have specific roles in 
muscular dystrophy symptoms. 
Collagen VI, a collagen associated with fibrosis, is increased in dystrophic 
muscle [81] and it is possible that collagen VI is deposed in excessive amounts 
and is inhibitory towards muscle function and metabolism. However, the 
relationship between muscle function and fibrosis is imprecisely understood. In a 
dystrophic mouse model where collagen VI was ablated, de Greef et al. found that 




fibrosis is beneficial [82]. Further, the experimenters found that, while total body 
mass and activity did not change significantly, there was a significant decrease in 
lean body mass. All aspects considered, the relationships between metabolism 
and fibrotic muscle are complicated. The effects of fibrotic deposition, disruption to 
the muscle, and whole body metabolic impairment may be relatable to outcomes 
following muscle injuries that result in fibrotic deposition, even though there is a 
different etiology. 
 
Sedentarism, Bedrest, and Immobilization 
The human body evolved to move in order to survive and only functions 
optimally with adequate physical activity. Without pressures such as hunger and 
threats to survival, humans in modern society are often inactive and sedentary, 
which contributes to decreased health and an increase in all-cause mortality 
[79,80]. Groups that are especially at risk of being sedentary and unfit are people 
that have suffered past orthopeadic injury [83,85,86]. 
There are a variety of ways that sedentarism and low physical activity 
contributes to poor health, including an increase in risk of being overweight or 
obese and decreased cardiac function [87]. A precursor to many of these 
maladaptive conditions is the development of metabolic inflexibility, a state where 
skeletal muscle has reduced sensitivity to insulin-signaled glucose uptake [88]. 
Since skeletal muscle makes up such a large portion of the human body, 
dysregulation of glucose metabolism in inactive skeletal muscle contributes 
strongly to the development of a plethora of disorders and diseases relating to 
metabolism, such as: type 2 diabetes mellitus, atherosclerosis, heart disease, 
obesity, non-alcoholic fatty liver disease, and osteoporosis [87]. 
Even more extreme examples of sedentarism are immobilization and bedrest. 
Skeletal muscles are especially affected by lack of use during immobilization and 
bedrest. A study conducted by Irimia and colleagues found dramatic onset of 
functional deficits during a prolonged period of bedrest [89]. Namely, in the lower 




output, and large decreases in oxidative gene expression. These changes have 
lasting implications when considering long-term outcomes. Following 
immobilization, muscles are resistant to rehabilitation and take longer to regain 
function, largely due to downregulation of PGC-1α [90]. 
 
Aging and Sarcopenia 
With age comes progressive decline of all systems in the body, including the 
muscular system [91]. Loss of muscle mass and function with advancing age, is 
termed sarcopenia. When considering chronic aspects of skeletal muscle injuries 
and conditions, sarcopenia may be an important comorbidity to consider. For 
instance, with aging comes persistent inflammation, muscle atrophy, and reduced 
muscle function [92,93]. It is difficult to delineate all factors surrounding sarcopenia 
because many factors covary with other aspects of sarcopenia. It is challenging to 
pinpoint to what degree atrophy occurs directly as a result of muscle aging 
because other systems that relate to muscle function, such as the circulatory and 
respiratory systems, also experience age related declines [91]. Further, decline of 
skeletal muscle, respiratory, and circulatory systems all contribute to the decline 
of mitochondrial function. However, mitochondrial dysfunction contributes to 
muscle atrophy [94], establishing a paradoxical situation where it is difficult to 
determine to what extent mitochondrial dysfunction contributes to muscular system 
decline, and vice versa. Regardless, it is theorized that loss of mitochondrial 
control mechanisms has a significant role in the development and propagation of 
sarcopenia. 
As humans age, mitochondrial quality control mechanisms (i.e., fission, fusion, 
and autophagy) decline [21]. Low quality mitochondria contribute to damage 
associated molecular patterns (DAMPS), which are the primary link between 
mitochondria and inflammation. One of the main DAMPs involving mitochondria is 
an impaired capacity to balance ROS, which eventually leads to mitochondrial 
lysing. Though mitochondria have formed a symbiotic relationship with eukaryotes, 




inciting the recruitment of white blood cells, further promoting inflammation [21]. 
Inflammation incited in this way is inhibitory to muscle function, and is observed in 
various types of muscle injury [95]. It may be important to consider how 
inflammatory cells may interact with muscle function and the health and function 
of the organism as a whole, especially when considering chronic outcomes 
following muscle injury. 
 
Volumetric Muscle Loss Injury 
In cases of severe orthopaedic trauma, such as from high-energy blast wounds 
or car accidents, individuals may sustain massive damage to their entire body. 
Following such trauma, the primary focus is triage. Modern medicine has increased 
survival rates for these injuries, leaving afflicted individuals with a new set of 
concerns. Traumatic injuries often have chronic consequences on whole organism 
function and health. This is especially true in cases of VML injury. 
Volumetric muscle loss injury occurs when skeletal muscle is damaged and 
abruptly removed, resulting in frank loss of skeletal muscle tissue and chronic fore 
loss [96]. Relatively small losses of muscle tissue (<30%) result in 
disproportionately severe functional losses anywhere from 30-80% [97,98]. These 
injuries are beyond the capacity of endogenous repair, resulting in chronic 
disablement. No therapeutic method allows a full recovery of function of the 
skeletal muscle. In fact, a recent meta-analysis by Greising and colleagues 
supports that, while treatment resulted in an approximate 16% improvement, the 
majority of the initial deficit remained, resulting in a relatively small overall effect 
when compared to non-injured controls [99]. In human, patients that suffer VML 
injury may expect poor outcomes despite substantial effort and expense during the 
course of treatment. 
Care for VML injury involves a lengthy time course of medical treatment, 
including, at a minimum, surgical fees and extensive physical therapy. The 
estimated cost to treat VML injury for an individual patient is expected to exceed 




[100]. It is difficult to quantify the total incidence of VML injuries since there is no 
ICD code. Based on the number of traumatic orthopaedic injuries in the armed 
services and civilian population, there are an expected significant number of VML 
cases per year [100,101]. Since these cases do not truly resolve, it can be implied 
that there will be a largely increasing number of patients undergoing treatment for 
the chronic aspects of VML injury, driving a need to develop a standard of care for 
these injuries. This is problematic, as the pathophysiology of VML injury is still 
incompletely understood. 
There are a multiple mechanisms to consider when attempting to characterize 
and understand the complexities underlying VML injury. The causes of VML injury 
vary, but they are often traumatic or surgical in nature. Following trauma, the focus 
of initial care is to mitigate vascular injury, infection, and address any bone injury. 
In this process, tissues at risk for necrosis are debrided, including skeletal muscle. 
It is unavoidable that such a loss of muscle from damage and debridement will 
cause an instantaneous loss of function. 
With traumatic loss of muscle comes a likely loss of nerve tissue. In a VML 
injury experiment conducted by Corona et. al, though motor neurons remained, 
axotomy occurred alongside VML injury [102]. The loss of neuromuscular 
structures contributes to the loss of function after VML injury in a few ways. Muscle 
fibers require stimulus from motor neurons to contract, so any loss of innervation 
will functionally reduce the total number of muscle fibers capable of contracting. 
Additionally, muscle fibers require innervation to remain viable, any loss of 
innervation to a muscle fiber will inevitably result in the death of that fiber [99]. 
Therefore, even if muscle fibers regenerate after VML injury, they will not survive 
without innervation. Within the complicated interplay of neuromuscular injury and 
attempted recovery, aspects of healing that are supposed to be beneficial—such 
as the inflammatory response—become malignant. 
Ordinarily the inflammatory response is an essential aspect of recovery 
following injury, however, the substantial inflammatory response after VML injury 




and chronic [97,104]. A lasting inflammatory response promotes an anti-
regenerative environment [105] that promotes fibrotic differentiation of progenitor 
cells [16]. While a recoverable injury will result in the downregulation of the fibrotic 
response after a few days to weeks, this is not the case in VML injury. Much like 
in the case of muscular dystrophies, fibrosis permeates the affected muscle. To 
some extent, the extensive fibrotic response after VML injury may be useful in 
preserving some degree of function. In a recent study, Corona et al. found that 
pharmacological mitigation of fibrosis resulted in a lower force output in the injured 
muscle, supporting that overly inhibiting fibrosis may be detrimental retained [106]. 
These findings suggesting that a functional fibrosis forms across the injury defect, 
allowing some aspects of force transmission to be retained. While fibrosis may act 
to preserve some function following VML injury, the ultimate goal of regenerative 
medicine is to repair the lost muscle with new, healthy muscle. True regeneration 
cannot occur without mediating the inflammatory response and reducing the 
extensive fibrotic development. 
While the most recognizable consequences of VML injury is a reduction in 
contractile function, robust inflammation, and fibrotic development, there are 
farther reaching consequences to organism health, including dysregulated skeletal 
muscle oxidative metabolism. Such impairments are readily observed by 
assessing the quality of oxidative muscle (e.g., type I fibers) and mitochondria. In 
a porcine study by Chao et al., VML injury resulted in an increase in the proportion 
of type I muscle fibers and increased mitochondrial number, however, type I fibers 
had reduced cross sectional area in VML-injured animals compared to controls 
and increased mitochondrial fission [107]. In a murine study by Aurora et al., the 
master regulator of mitochondria, PGC-1α, as expected was upregulated in 
response to rehabilitation in uninjured, but unexpectedly not in VML-injured 
animals [108]. Recently, Southern et al. found that the mitochondrial network is 
dysregulated after VML in a murine model [98]. Notably, Southern and colleagues 
found that overexpression of PGC-1α by means of transfection was able to rescue 




compared to controls, a torque deficit of ~45% remained. These findings support 
initial evidence that oxidative metabolism is impaired following VML injury, and that 
mitochondrial functions may provide insight into potential routes of treatment, 
however, there is a lack research on how whole-body metabolism is affected by 
VML injury. 
 
The major gaps in the current understanding go beyond muscle-specific 
metabolism and relate to how whole-body metabolism is affected by VML. This 
understanding is multifold. While poor metabolic outcomes are hypothesized 
following orthopaedic trauma, it is unknown how whole-body metabolism is 
affected following VML injury. No study to date has characterized whole-body 
metabolism in any organism following VML injury. Additionally, literature is lacking 
evaluation of physical activity levels following VML injury, either initially or well into 
the recovery period. Patients are expected to undergo bedrest and sedentarism 
following the initial VML injury, but it is unknown if animal models of VML exhibit 
similar patterns. Further, while it is clear that skeletal muscle function is severely 
impaired following VML injury, it is unclear how physical activity and metabolic 
function is linked to muscle contractile and oxidative activity, capillarity, and muscle 
fiber type distribution. To address the important questions raised above, my thesis 
had the following specific aims and hypotheses: 
 
Specific Aim 1: Characterize physical activity and metabolism in mice 
chronically following VML injury.  
Hypothesis 1: Physical activity will be reduced both acutely and 
chronically as a result of VML. This impairment is expected to 






Specific Aim 2: Determine how VML injury impairs contractile and 
oxidative profile by assessing force output, muscle fiber cross 
sectional area, mitochondrial enzyme activity, and capillarity. 
Hypothesis 2: Skeletal muscle will present functional and metabolic 
impairments in response to VML injury, including reduced force 
generating capacity, lower fiber cross-sectional area, reduced 
mitochondrial enzyme function, and lower capillarity.  
 
These specific aims and hypotheses are addressed in Chapter 2, which include 
the final manuscript of my research project (in preparation for submission to BMC 











Background: Volumetric muscle loss (VML) injuries result in a non-recoverable 
loss of muscle tissue and function due to trauma or surgery. Broadly, reductions in 
physical activity, as observed following orthopedic injury, increases the risk of 
metabolic inflexibility, a state where inefficiencies in fuel utilization may result in 
disease and comorbidity. It is likely that whole-body physical activity and 
metabolism are reduced post-VML injury, however these aspects remain 
uncharacterized. Our goal was to characterize whole-body physical activity and 
metabolism following VML injury, and to further investigate possible muscle fiber 
specific changes. Methods: Adult male C57Bl/6J (n=28) mice underwent a 
standardized VML injury to the posterior compartment of the hind limb (or control). 
Mice underwent longitudinal evaluation of whole-body physical activity and 
metabolism in specialized cages up to three times over the course of 8-weeks. At 
terminal time points of 4- and 8-week post-VML in vivo muscle function of the 
posterior compartment was elevated. Additionally, gastrocnemius muscle was 
collected to understand histologically and biochemically changed in the muscle 
remaining after VML. Results: The VML injury to the hind limb resulted in changes 
to the muscle and whole-body metabolism, despite no changes in physical activity. 
Reductions in whole-body metabolism occurred, largely driven by lower 
carbohydrate utilization during active hours. Contractile function of the injured limb 
was impaired due to a loss of fast muscle fibers, while slow muscle fibers were 
maintained. Though slower, oxidative muscle proportion increased, capillarity and 
biochemical activity of the muscle were not improved. Though there was an acute 
increase in activity of complex I of the electron transport chain, a lack of increase 
in up or downstream mitochondrial enzymes supports that mitochondrial 
uncoupling may occur following VML, which may contribute to impaired glucose 
metabolism and an increased risk of metabolic comorbidity. Conclusions: These 
findings support that alterations in VML-injured muscle may lead to impairments in 
whole-body metabolism. Future therapeutic efforts may be needed to improve 





As the primary organ of movement and thermogenesis [1], skeletal muscle 
must utilize fuel from energy yielding sources, primarily carbohydrates for high 
workloads [109] and lipids for low workloads and rest [110]. Transitions between 
fuel sources occur due to various demands on the body and is represented by the 
degree of metabolic flexibility. Metabolically healthy individuals are able to 
efficiently transition between fuel sources with changing energetic demand, such 
as when transitioning between activity and rest, as well as times of fasting and 
feeding [88]. Energetic demands during exercise are an excellent example of 
robust metabolic flexibility as the body can physiologically match fuel availability 
with energy demands. In contrast, as individuals become metabolically unhealthy, 
such as in pathologic conditions of type II diabetes and obesity, they tend to 
become metabolically inflexible, or inefficiently able to transition between fuel 
sources [111]. Inactivity and lack of exercise are linked to greater all-cause 
mortality and have been shown to cause atherosclerosis, reduced cardiac function, 
type II diabetes, and obesity [87]. Further, physical inactivity has been implicated 
as a factor driving the onset of metabolic inflexibility [112,113]. Given that skeletal 
muscle is the primary organ of movement and lack of movement is linked to 
metabolic inflexibility, conditions that impair the ability of muscle to do physical 
work, such as orthopaedic traumas, may increase the risk of metabolic impairment 
in affected individuals both acutely and chronically. 
Large-scale orthopaedic traumas have broad implications on long-term health 
and function and can potentially increase risk for metabolic comorbidities. For 
example, in patients who sustained fracture to the upper or lower extremities there 
are known decreases in physical activity and increases in sedentarism acutely 
following injury [85,86]. Similarly, various orthopaedic injuries and traumas result 
in decreases in physical activity as early as three months after initial injury [114]. 
One injury of particular significance is volumetric muscle loss (VML) injury, in which 
a substantial piece of a muscle or muscle unit is abruptly removed, resulting in 




comorbidities secondary to VML injury are not well understood, however, it is 
expected that there is a loss of skeletal muscle metabolic and physical activity. It 
is anticipated that after initial VML injury there will be periods of reduced 
mobilization that are unavoidable during prolonged care. It is thus hypothesized 
that patients with VML injury could be more likely to undergo periods of reduced 
physical activity and subsequently develop metabolic inflexibility chronically. 
We posit that the sequela of VML injury includes impaired whole-body 
metabolism due to low physical activity and the loss of skeletal muscle tissue. 
Previous work in animal models of VML has indicated that skeletal muscle specific 
oxidative function is impaired following injury [98,107], and that the muscle 
remaining after VML injury has reduced metabolic plasticity compared to healthy, 
uninjured muscle in response to rehabilitation [116]. Dysfunction of skeletal muscle 
metabolism may impede the endogenous healing process and induce further 
chronic dysfunction. To date it is unknown to what extent VML injury impacts 
whole-body metabolism and physical activity both in animal models of VML injury 
or the patient population. The studies herein were designed to first understand if 
VML injury results in reduced physical activity and whole-body metabolism 
corresponding to chronic metabolic inflexibility. Second, to evaluate contractile and 
oxidative physiology of the skeletal muscle fibers after VML injury. 
 
Methods 
Animals and Study Design 
Adult male C57Bl/6J (n=28) mice were purchased from Jackson Laboratories 
(Stock # 000664; Bar Harber, ME). Mice were allowed at least one week of 
acclimation to the facility prior to initiating any aspect of the study protocol. All 
protocols and animal care guidelines were approved by the University of 
Minnesota Institutional Animal Care and Use Committee (Protocol 1803-35671A), 
in compliance with the National Institute of Health Guidelines and the United States 
Department of Agriculture. All studies were conducted in compliance with the 




accordance with the principles of the Guide for the Care and Use of Laboratory 
Animals. 
Mice were housed on a 12-hour light-dark cycle (light phase begins at 06:00) 
with ad libitum access to standard chow and water. At ~12.5 weeks of age mice 
were allocated by rank order scheme assignment of respiratory exchange ratio, 
into VML injury (n=12), sham surgery (n=12), or injury naïve controls (n=4). Mice 
in the sham and naïve groups were not different and combined into a control group. 
Physical activity and metabolic assessments were conducted using 
Comprehensive Lab Animal Monitoring System (CLAMS; Columbus Instruments) 
at approximately 1-week pre-surgery and 2- and 6-weeks post-surgery for all 
animals. In vivo muscle function was assessed terminally 4- and 8-weeks post-
surgery. Immediately following muscle function assessments, mice were 
euthanized with pentobarbital (>100mg/kg; s.q.), and skeletal muscles were 
harvested and frozen at -80oC for later analyses. 
 
Physical Activity and Metabolic Assessment  
Mice were acclimated to individual CLAMS cages for 24-hours prior to each 
data collection period. The CLAMS system is a closed chamber that measures 
ventilation gases O2 and CO2 normalized to body mass (ml/kg/hr) to quantify 
metabolic activity. The respiratory exchange ratio (RER) is calculated as the 
volume ratio of CO2 and O2. Calorific value (CV) is the relationship between heat 
and oxygen consumption, as described in Graham Lusk’s “The Elements of the 
Science of Nutrition” [117] by the following equation: CV = 3.815 + 1.232 * RER. 
Further, energy expenditure (i.e., heat) is calculated as the product of the CV and 
the VO2 of the mouse and represents the metabolic rate. 
Each CLAMS cage is equipped with infrared beams in the X, Y, and Z axes 
that register physical movement when the beam array is broken. Individual beam 
breaks are classified as activity counts. When the mouse is moving in the same 
position (i.e., grooming, drinking, and feeding), the movement is tracked as a 




ambulatory counts. Beams along the X and Y axis are spaced at 1.27cm intervals, 
allowing quantification of ambulatory distance.  
Data were collected and analyzed using CLAMS data examination Tool (Clax, 
v2.2.15; Columbus Instruments), a software integrated with CLAMS for the 24-
hour periods. Data for total counts and ambulatory counts were collected in 10-
second increments, and RER, metabolic rate, VO2 and VCO2 were collected in 4-
minute increments. All data were subsequently exported for later analyses. 
Overall data were analyzed in bins of 24, 12 (active vs. inactive time periods), 
6, and 1 hour and presented as a mean over the time period. Metabolic flexibility 
was measured by assessing the range of metabolic rate and RER as the delta 
between 12-hour active and inactive values. Each incremental RER and metabolic 
rate data were also used to calculate hourly moving averages using an average of 
every 15, 4-minute increment. The moving averages were used to evaluate the 
area under the curve (AUC) as a more specific measure of metabolic flexibility. 
 
Volumetric Muscle Loss (VML) Surgical Procedure 
As previously described [98,116], the VML injury was a full thickness injury to 
the posterior compartment muscle group (gastrocnemius, soleus, and plantaris 
muscles). A subset of mice underwent sham VML procedures or no surgical 
procedure (injury naïve). About 2 hours prior to surgery mice received SR 
buprenorphine (1.2mg/kg; s.q.) for pain management. Mice were anesthetized 
using isoflurane (1.0-3.0%) under aseptic surgical conditions. A posterior-lateral 
incision was made through the skin to reveal the gastrocnemius muscle. Blunt 
dissection was used to isolate the posterior muscle compartment, and a metal 
plate was inserted between the tibia and the deep aspect of the soleus. A 4 mm 
punch biopsy (20.9±4.9 mg, ~15% volume loss of muscle) was performed on the 
middle third of the muscle compartment. Any bleeding was stopped with pressure. 






In vivo muscle function 
At the terminal time point (4- or 8-weeks post-injury) the isometric torque of the 
posterior compartment muscle was evaluated as previously described [98,116]. 
Briefly, in vivo isometric torque was measured in anesthetized mice (isoflurane 
1.5–2.0%) while body temperature was maintained at 37oC. The foot was 
positioned to a footplate attached to a dual‐mode muscle lever system (Model 129 
300C-LR; Aurora Scientific, Aurora, Ontario, Canada). The knee was secured 
using a custom‐made mounting system, and the ankle was positioned at a 90o 
angle. First, under computer control of the servomotor, the ankle was passively 
rotated 20o from neutral in both the plantar- and dorsi-flexion directions (total 40o 
of motion). Second, to avoid recruitment of the anterior compartment muscles, the 
common perineal nerve was severed. Platinum-Iridium percutaneous needle 
electrodes were placed across the sciatic nerve, which branches to the tibial nerve. 
Then optimal muscle stimulation was achieved by finding peak-isometric torque by 
increasing the current in increments of 0.2 mAmps. The force frequency 
relationship was assessed by measuring torque as a function of the following 
stimulation frequencies: 5, 10, 20, 40, 60, 80, 100, 150, and 200 Hz. Isometric 
torque is expressed as mN·m to determine absolute functional capacity or per kg 
body weight to assess functional quality. 
 
Biochemical Analysis 
At the terminal time points, the proximal and distal thirds of the gastrocnemius 
muscle of all animals were snap frozen using liquid nitrogen and subsequently 
stored at -80°C until biochemical analysis. The distal third portion was weighed 
and homogenized in 10mM phosphate buffer (pH 7.4) at a ratio of 1:10 (mg/µl), 
using a glass pestle tissue grinder. Total protein content was analyzed in triplicate 
and averaged using the Protein A280 setting on a NanoDrop One 
spectrophotometer (Thermo Scientific). Mitochondrial content was analyzed by 
citrate synthase enzyme activity as previously described [98]. The proximal third 




phosphate buffer (pH 7.4) at a muscle to buffer ratio of 1:40 using a glass tissue 
grinder. Homogenate was incubated with 5,5’-dithio-bis (2-nitrobenzoic acid 
(DTNB, 0.773 mM), acetyl CoA (0.116 mM), and oxaloacetate (0.441 mM) in 100 
mM Tris buffer (pH 8.0). Activity of citrate synthase activity was monitored from the 
reduction of DTNB over time via measurement of absorbance at 412 nm. 
 
Histological and Morphologic Analyses of Muscle Fibers 
At harvest, the middle third of the gastrocnemius muscle of all animals was 
isolated for histological evaluation. Muscles were mounted on cork using 
tragacanth gum, frozen in 2-methylbutane cooled by liquid nitrogen, and 
subsequently stored at -80°C. Ten µm sections of the mid-belly of the 
gastrocnemius muscle were collected using a Leica cryostat and microtome. Serial 
sections were stained first with Masson’s Trichrome for qualitative analysis of 
skeletal muscle fibers and fibrotic deposition and quantification of centrally-located 
nuclei. Subsequently, sections were stained to quantify capillarity, nicotinamide 
adenine dinucleotide hydrogen (NADH)- tetrazolium reductase and succinate 
dehydrogenase (SDH) to identify and quantify the proportion of oxidative muscle 
fibers, and myosin heavy chain (MyHC) fiber type composition. 
Capillarity was assessed by staining for alkaline phosphatase activity [118]. 
Muscles were incubated in alkaline phosphate buffer for one hour at 37°C. 
Sections were then washed, incubated with 0.25% metanil yellow for five minutes, 
and washed again. NADH-TR staining was performed by incubating tissues at 
37°C for 20 minutes in a solution containing 0.2M Tris, 1.5 mM NADH, and 1.5 mM 
NBT [119]. Sections were washed, dehydrated, and cleared in xylenes. SDH 
staining was performed by incubating tissues at 37°C for one hour in a 0.2M 
sodium phosphate buffer solution [120]. Tissues were rinsed, dehydrated in graded 
acetone dilutions, and rinsed again. 
Frozen muscles were also analyzed for MyHC isoform expression. Staining of 
the gastrocnemius muscle was completed with a combination of primary 




5µg/ml), and anti-MyHC2B (BF-F3, 5µg/ml) all acquired from the Developmental 
Hybridoma Studies Bank (Iowa City, IA). Additionally, sections were stained with 
wheat germ agglutinin (Invitrogen W7024, 1 µg/ml) to identify the sarcolemma. 
Appropriately paired secondary Alexa-Fluor (Invitrogen A21240) and DyLight 
(Jackson ImmunoResearch 115-475-207 or 115-545-020) conjugated antibodies 
at a dilution of 1:200 were used. In all cases, the expected staining patterns in 
normal skeletal muscle were observed and the specificity of anti-labeling was 
confirmed by the absence of staining outside expected structures and was 
consistent with manufacturer’s technical information. The specificity of the MyHC 
isoform antibodies has been previously validated [121] and is representative of our 
previous work [122,123]. 
All brightfield images were acquired using the TissueScope LE slide scanner 
(Huron Digital Pathology, St. Jacobs, ON, Canada) using a 20X objective (0.75 
NA, 0.5 µm/pixel resolution). Following imaging, using HuronViewer (Huron Digital 
Pathology), three standardized regions of interest (ROI) were selected for each 
muscle and exported for analysis. All ROIs were standardized to 500 x 500µm. 
One ROI was created to encompass the area immediately adjacent to the defect 
region of the VML group and two ROIs encompassed the remaining skeletal 
muscle tissue on medial and lateral side of the defect region. The corresponding 
three ROI areas were also obtained in muscles of the control groups. All ROIs were 
systematically used across all muscles from the same animal. The ROIs were first 
evaluated independently within the respective region (lateral, mid-muscle, and 
medial). Subsequently, data from these ROIs were either summed or averaged 
across the gastrocnemius muscle and compared across groups. 
Fluorescent images of all muscles stained for MyHC isoform expression was 
conducted using a Nikon C2 automated upright laser scanning confocal 
microscope equipped with a Plan Apo λ 20x objective and dual GaSP detectors 
(Nikon Instruments Inc., Melville, NY). Image sampling was determined using 




2048. Images were collected from the same three ROIs previously described. All 
ROIs were subsequently saved and exported for analysis. 
Analyses of muscle sections were conducted using Fiji [124]. The multipoint 
tool was used to manually count muscle fibers, centrally located nuclei, and 
capillaries, as well as the number of darkly and lightly stained muscle fibers for all 
NADH and SDH stained muscle. Darkly stained fibers were classified as positive 
for NADH and SDH, indicating high metabolic activity, while lightly stained fibers 
were classified as negative for NADH and SDH, suggesting low metabolic activity. 
Fibers of the gastrocnemius muscle were classified signally as type I, IIa, and IIb 
based on the expression of MyHCslow, MyHC2A, and MyHC2B, respectively. Fibers 
were classified as type IIx based on the absence of staining. Additionally, muscle 
fiber cross-sectional area (CSA) was measured for each section using the 
freehand tool and quantified as fiber-type specific CSA. Muscle CSA was only 
quantified for fibers between 50-7,500µm2. For display purposes only, images 
were down-converted, without introducing any changes in brightness or contrast 
and produced in Adobe Photoshop (Adobe Systems Inc.). During all imaging laser 
intensity was kept consistent across imaging of the same probes. Investigators 
were blinded during all imaging and post-imaging analyses. 
 
Statistical Analyses  
Data analysis was conducted using JMP (version 14.3.0, SAS Institute, Inc.) 
and Prism (version 9, GraphPad Inc). For metabolic and physical activity data, one-
way ANOVAs were used to evaluate differences across time frames of 1-, 6-, 12-, 
and 24-hr periods. Longitudinal differences across time, pre-VML and 2- and 6-
weeks post-VML were calculated using means and AUC, differences were 
evaluated using one-way, repeated measures, ANOVA. One-way ANOVAs were 
used to evaluate differences across groups for body weight, muscle weight, muscle 
function, histologic parameters, and protein and enzyme content. Two-way 
ANOVAs were used to evaluate overall muscle fiber-type specifics differences 




evaluated by chi-squared, and alpha was corrected for multiple comparisons at 
0.167. When appropriate Tukey’s HSD post hoc was evaluated, significance was 




During the pre-VML metabolic and physical activity evaluation, mice weighed 
27.7±2.0g on average. As expected, mice gained weight over the 4- and 8-week 
period, with an average terminal body mass of ~30 and 31g, respectively (Table 
2). Body weight was not significantly different between experimental groups at any 
time during the study duration (p=0.123). Following all surgical procedures mice 
recovered promptly and no adverse events were identified. 
Table 2. Contractile properties following VML injury 
 Control  VML 4-week VML 8-week p-value 
 (n=16) (n=5) (n=7)  
Body weight (g)  30.5 ± 0.6 29.3 ± 1.1 31.1 ± 0.9 0.427 
Gastrocnemius weight ratio 1.08 ± 0.08 0.84 ± 0.07 * 0.92 ± 0.15 * <0.001 
Passive torque (mN·m) 2.4 ± 0.5 4.2 ± 1.4 * 5.1 ± 1.4 * <0.0001 
Peak twitch 5Hz (mN·m) 4.1 ± 0.9 2.9 ± 0.7 * 1.9 ± 1.0 * <0.0001 
Peak torque (mN·m) 19.2 ± 2.5 12.3 ± 1.2 * 9.9 ±2.4 * <0.0001 
Twitch:tetani ratio 0.21 ± 0.01 0.23 ± 0.02 0.19 ± 0.02 0.313 
Data analyzed by one-way ANOVA, presented as mean ± SD. Different than *control 
 
Baseline physical and metabolic activity 
Prior to allocation into experimental groups, all mice were analyzed for 24-hour 
physical and metabolic activity. At this baseline time point, mice ambulated 
1.3±0.3km over 24 hours, with ~1km ambulated during the active period (i.e., dark 
hours of 18:00-06:00) and the remaining over the inactive period (i.e., light hours 
of 06:00-18:00). Over the course of 24 hours, the average metabolic rate was ~19 
kcal/hr, with an expected greater metabolic rate during the active period (~21 
kcal/hr) and lesser during the inactive period (~17 kcal/hr, p<0.001; Figure 1A). 
Metabolic flexibility, as quantified by the delta metabolic rate, was approximately 
4.5kcal/hr. Metabolic rates fluctuated between 19-24 kcals/hr during the active 




(p<0.001; Figure 1C). During the inactive period, metabolic values fluctuated 
between 15-19 kcal/hr with the greatest values occurring during the transition from 
active to inactive, around 05:00-08:00 hours. Hourly metabolic rate was typically 
below 17 kcals/hr during the rest of the inactive time period (p<0.001). 
The RER over the course of 24 hours was ~0.90, with a RER of ~0.93 during 
 
Figure 1: Mice were evaluated for whole-body metabolism and physical activity ~1-week prior 
to allocation into experimental groups, data was collected over 24 hours in a specialized closed 
cage system; while mice were housed in a 12-hour light: dark environment matching the inactive 
and active time periods, respectively. Both metabolic rate and respiratory exchange ratio (RER) 
were analyzed in 1-, 12-, and 24-hour bins. A) Metabolic rate was highest during the 12-hour 
active period, which was significantly greater than during the 12-hour inactive period (p<0.001). 
B) The total area under the curve (AUC) for metabolic rate was 5936±33. C) In 1-hr bins the 
greatest metabolic rate recorded during the active period. D) Similarly, the greatest RER 
occurred over the 12-hour active period, which was significantly greater than RER during the 
inactive period (p<0.001). E) The RER followed the same trend as the metabolic rate, with an 
AUC of 63.8±0.61, and F) the greatest RER values occurred during the active period, 
suggestive of greater carbohydrate utilization during this phase. Data presented as mean±SD; 




the active period but only ~0.87 during the inactive period (p<0.001; Figure 1D), 
suggesting a greater carbohydrate utilization during the active period, and greater 
lipid utilization during the inactive period. Hourly RER fluctuated between 0.90-
0.96 during the active period, with a gradual decline during the transition to the 
inactive period from 05:00-11:00. Inactive RER values fluctuated between 0.84-
0.93, with the lowest values occurring during the middle of the active period from 
11:00-13:00, then gradually increasing from through 17:00 (p<0.001; Figure 1F). 
 
VML-induced changes in physical and metabolic activity 
Following VML injury both physical and metabolic activity were longitudinally 
evaluated in a subset of mice at pre-, 2- and 6-weeks post-VML surgery. There 
was no difference in physical activity, specifically ambulatory distances, 
longitudinally after VML injury. The total distances ambulated for pre-, 2- and 6-
weeks post-VML were 1.3±0.3, 1.4±0.2, and 1.4±0.4km, respectively (p=0.809). 
As expected, most of the ambulatory activity occurred during the active time 
period. 
Longitudinal metabolic activity measurements supported a decrease in 
metabolic rate by 6-weeks post-VML, specifically the 24-hour metabolic rate 
decreased ~10% compared to pre- and 2-weeks post-VML (p=0.012; Figure 2A). 
Similarly, metabolic rate was decreased ~9% by 6-weeks post-VML during the 
active period compared to 2-weeks post-VML (p=0.032) and was reduced ~12% 
by 6-weeks compared to pre- and 2-weeks post-VML, during the inactive period 
(p=0.092; Figure 2A). There was no difference in delta metabolic rate at any time 
point evaluated (p=0.988; Figure 2B). To specifically evaluate possible differences 
in metabolic flexibility, metabolic rate was also compared across time points with 
the calculated AUC. The 24-hour metabolic rate AUC was significantly decreased 
by 6-weeks post-VML (5,400±30) compared to pre- and 2-weeks post-VML 
(5948±33 and 6026±30, p<0.001; Figure 2C). Subsequently, the AUC was 
evaluated in 6-hour bins. Within each active 6-hour bin, the metabolic rate 6-weeks 




VML time points (p≤0.001; Figure 2C). Only during the second phase of the 
inactive period (00:00–06:00) was the metabolic rate at 2-weeks post-VML 
different from pre-VML (p=0.007; Figure 2C). 
In addition to metabolic rate, RER was evaluated longitudinally. At 6-weeks 
post-VML 24-hour RER was significantly reduced by ~4% compared to the pre-
VML (p=0.014), likely due to the reduction in RER during the active time (p=0.003; 
Figure 2D). There was no difference in the delta RER over time (p=0.530; Figure 
2E). The 24-hour metabolic flexibility in RER was significantly lower at 2- and 6-
weeks post-VML compared to pre-VML (AUC 279±1, 284±1 vs. 291±1, p<0.001; 
Figure 2F). The RER during the active period was greatest pre-VML, and lowest 
 
Figure 2: In a subset of mice, longitudinal evaluation of metabolic rate and RER was conducted 
pre-VML surgery and at 2- and 6-weeks post-VML surgery. A) By 6-weeks post-VML, mice had 
an ~10% decreased metabolic rate during the 24-hour and 12-hour active periods, compared 
to 2-weeks post-VML (p≤0.050). B) No differences were observed across time for the delta in 
metabolic rate between the active and inactive periods (p=0.988). C) Metabolic rate was 
evaluated by comparing the AUC values across time. When broken into 6-hour bins, significant 
differences are noted across time points within each bin, with mice at 6-weeks post-VML 
demonstrating the lowest metabolic rate in each 6-hour bin (p≤0.007). D) The RER at 6-weeks 
post-VML was decreased ~4% over 24 hours compared to the pre-VML, indicating reduced 
carbohydrate oxidation and daily caloric expenditure (p=0.013). This decrease was likely due 
in part to a significant reduction in RER which occurred during the active period by 6-weeks 
post-VML (p=0.002). E) There were no differences across time were determined for the delta 
RER (p=0.530). F) At 2-weeks post-VML, mice exhibited a lower RER as determined by AUC 
compared to pre-VML, and a further significant reduction in RER at 6-weeks post-VML, 
indicating progressively impaired metabolic flexibility 2- and 6-weeks post-VML compared to 
baseline (p<0.001). When analyzed in 6-hour bins, significant differences were observed across 
evaluation time points for each bin (p≤0.001). Data presented as mean±SD; analyzed by one- 




at 6-weeks post-VML, particularly during the first 6 hours of the active period 
(p<0.001; Figure 2F). A similar pattern was observed during the inactive period, 
in which the RER pre-VML was the greatest, while at 6-weeks post-VML RER was 
the lowest, especially during the second phase of the inactive period (p<0.001; 
Figure 2F). Collectively, indicating an impairment in metabolic flexibility up to 6-
weeks following VML injury. 
 
In vivo muscle function 
The VML injury to the posterior compartment resulted in an ~22% reduction of 
gastrocnemius mass at 4-weeks, and ~15% reduction at 8-weeks (p<0.001; Table 
2). The passive torque at 20o of dorsiflexion was determined as a surrogate of 
passive muscle stiffness. The VML injury resulted in a significant increase in 
passive torque about the ankle joint by ~2 fold at 4-weeks and 8-weeks (p<0.001; 
Table 2 & 
Figure 3). 
The VML 
injury did not 
impact the 
twitch to 





There was no difference in the force-frequency (1-300 Hz) relationship of the ankle 
plantar flexor muscles, maximal torque was reached at a frequency of 200 Hz, and 
the ~50% torque deficit in the VML group was observed at various frequencies 
from 40-80 Hz. Compared to controls, maximal isometric torque of the ankle 
plantar flexor muscles decreased by about 50% at both 4-weeks and 8-weeks 
 
Figure 3: In vivo muscle function was normalized for body weight. A) The 
passive torque of the ankle plantar flexor muscles at 20° dorsiflexion was 
greatest at both 4- and 8-weeks following VML (p<0.001). B) The peak 
isometric torque of the ankle plantar flexor muscles was significantly reduced 
at both 4- and 8-weeks following VML (p<0.001). Data presented as 




post-VML (p<0.001; Table 2 & Figure 3). Both absolute and torque normalized to 
body mass were significantly impaired by VML injury.  
 
Biochemical analysis of gastrocnemius muscles 
The remaining gastrocnemius muscle had minimal VML-induced changes to 
total protein content (p=0.674). Similarly, citrate synthase activity, a surrogate of 
mitochondrial abundance, was also unchanged (p=0.444). There were also no 
differences in succinate dehydrogenase activity (p=0.128). Collectively, 
biochemical aspects of the gastrocnemius appear largely unchanged post-VML 
(Table 3). 
Table 3. Biochemical composition of gastrocnemius muscle following VML  
 Control  VML 4-week VML 8-week p-value 
 (n=16) (n=5) (n=7)  
Total protein content 
(mg/mg muscle) 
20.4 ± 3.4 19.3 ± 3.6 18.7 ± 2.4 0.674 
Citrate synthase 
(µmol/min/g) 
498.8 ± 75.4 458.0 ± 77.8 480.3 ± 116.3 0.444 
Succinate 
dehydrogenase activity 
(µmol cyto c/min/g) 
4.93 ± 0.68 4.12 ± 0.95 4.86 ± 0.80 0.128 
Data analyzed by one-way ANOVA, presented as mean ± SD 
 
Histological analysis of gastrocnemius muscles 
Whole muscle and regional histologic characteristics of gastrocnemius muscles 
were evaluated terminally across experimental groups. In comparison to control 
muscles, qualitative examination showed fibrotic development in muscles post-
VML with some muscle fibers that appeared smaller in size and irregular in shape 
and there was an abundance of centrally-located nuclei, particularly in the medial 
portion of the muscle near the initially created VML injury (Figure 4). 
Specific changes in the VML-injured gastrocnemius muscle fibers were 
quantified across the muscle (Table 4). The lateral and medial regions did not 
experience a change in capillaries per fiber (p≥0.345), while the mid-region 
bordering the VML defect demonstrated a reduction in capillaries at 4-weeks and 
an increase at 8-weeks post-VML (p=0.041). Across the entire gastrocnemius 




muscle at both 4- and 8-weeks post-VML compared to control (p<0.001). Between 
the 4- and 8-weeks post-VML groups there was also a leftward shift in capillary 
distribution (p=0.001), in parallel with an increased proportion of capillaries per 
fiber at the tail ends of the distribution curve (Figure 5A). There were no 
differences between groups in the number of capillaries per muscle fiber across 
the whole gastrocnemius muscle (p=0.154; Figure 5B). 
 
 
Figure 4: Histologic evaluation of the 
gastrocnemius muscle occurred at 4- 
and 8-weeks following VML injury and 
in control muscles. A) Representative 
whole gastrocnemius muscles for 
each group. Three standardized 
regions of interest were evaluated for 
each muscle (boxes), representing 
the lateral and medial aspects of the 
gastrocnemius muscle, as well as a 
mid-gastrocnemius region which is at 
the point adjacent to the VML injury. 
Scale bar is 1mm. B) Serial sections 
of the gastrocnemius muscle were 
stained for various physiologic and 
oxidative characteristics, and 
representative images from the 
medial/defect region are shown. 
Masson’s Trichrome (staining muscle 
fibers red; fibrosis blue; nuclei black) 
was used to evaluate muscle quality 
and centrally located nuclei. NADH 
and SDH were used to evaluate 
oxidative enzymes, with darker 
stained fibers indicating fibers positive 
for NADH or SDH, respectively. 
Alkaline phosphatase was used to 
evaluate capillarity of fibers (staining 
muscle fibers yellow; capillaries 
black). Myosin heavy chain (MyHC) 
isoform expression was evaluated 
using antibodies for MyHCslow, 
MyHC2A, and MyHC2B, or the absence 
of staining indicating types I, IIa, or IIb 
fibers, type IIx fibers in blue, red, 
green, or black, respectively. Scale 





Table 4. Histologic composition of the muscle following VML 
 Control VML 4-week VML 8-week p-value 
Lateral Gastrocnemius 
NADH positive fibers (%) 75.1 ± 11.8 87.2 ± 2.7 85.0 ± 11.2 0.088 
SDH positive fibers (%) 53.7 ± 20.2 72.5 ± 19.5 67.7 ± 16.8 0.163 
Fibers with centrally located nuclei 
(%) 
7.2 ± 8.2 20.2 ± 9.6 33.1 ± 31.6 * 0.013 
Mean capillaries per fiber 5.6 ± 1.1 4.4 ± 1.0 4.8 ± 1.1 0.698 
Mid-Gastrocnemius; VML border 
NADH positive fibers (%) 63.0 ± 18.0 78.7 ± 13.3 72.8 ± 15.9 0.202 
SDH positive fibers (%) 30.6 ± 21.5 34.0 ± 23.6 25.8 ± 13.4 0.788 
Fibers with centrally located nuclei 
(%) 
1.6 ± 2.3 28.1 ± 14.1 * 18.7 ± 9.2 * <0.001 
Mean capillaries per fiber 3.6 ± 1.1 2.7 ± 1.0 * 3.9 ± 1.1 * 0.041 
Medial Gastrocnemius 
NADH positive fibers (%) 71.5 ± 15.5  91.3 ± 1.5 * 59.6 ± 21.2  0.036 
SDH positive fibers (%) 58.0 ± 13.8 66.4 ± 19.2 58.0 ± 16.0 0.663 
Fibers with centrally located nuclei 
(%) 
8.2 ± 12.8 21.8 ± 16.3 * 29.7 ± 13.9 * 0.005 
Mean capillaries per fiber 4.6 ± 1.1 5.3 ± 0.6 5.2 ± 1.2 0.345 
Data analyzed by one-way ANOVA, presented as mean ± SD. Different than * control 
 
The percentage of muscle fibers with centrally located nuclei was greater in the 
medial and mid-gastrocnemius regions at 4-weeks post-VML and in all regions at 
8-weeks post-VML (p≤0.013; Table 4). At 8-weeks post-VML across the whole 
muscle, there was a greater percentage of central nuclei than controls (p<0.001) 
but a similar percentage to muscles at 4-weeks post-VML (p=0.395). There were 
no differences in the percentage of central nuclei between muscles of controls or 
at 4-weeks post-VML (p=0.338; Figure 5C). In examining the oxidative capacity of 
the muscle, expression of NADH-positive fibers was only different 4-weeks post-
VML in the medial region compared to control (p=0.036), while no differences in 
SDH-positive fibers were observed in any region at any time point (p≥0.163; Table 
4). Across the whole muscle, there was an increase in NADH-positive muscle 
fibers at 4-weeks post-VML compared to control but not compared to 8-weeks 
post-VML (p≥0.022). No differences in the percentage of NADH-positive fibers 
were observed between controls and 8-weeks post-VML (Figure 5D). There were 
no differences in percentage of SDH-positive muscle fibers across control, 4- or 8-




Gastrocnemius muscles were evaluated for fiber type specific differences in 
 
Figure 5: Capillarity and oxidative activity were evaluated in gastrocnemius muscle and 
compared across control, 4- and 8-weeks post-VML. A) The distribution of capillaries was 
significantly different at both 4- and 8-weeks post-VML compared to controls (p<0.001) and 
between groups at 4- and 8-weeks post-VML (p<0.001). B) There were no differences in the 
average number of capillaries per gastrocnemius muscle fiber (p=0.154). C) Compared to 
controls, muscles at 8-weeks post-VML had a greater percentage of centrally located nuclei 
(p=0.007), and this was similar to muscles at 4-weeks post-VML (p=0.338). D) There was a 
significant increase in NADH-positive fibers 4-weeks post-VML compared to controls (p=0.016) 
but not compared to 8-weeks post-VML (p=0.059). E) There were no significant differences 
were observed between control, 4- or 8-weeks post-VML (p=0.625). Data presented as 




fiber cross-sectional area following VML injury. Compared to control, the 
distribution of muscle fiber cross-sectional area shifted left at 4- and 8-weeks post 
VML (p<0.001), and VML groups were not significantly different than each other 
(p<0.017; Figure 6A). Within the gastrocnemius, fiber-type specific cross-sectional 
areas did not vary between groups at any time point (p≥0.070; Table 5). However,  
Table 5. Fiber type specific size of gastrocnemius muscle following VML 
 Control VML 4-week VML 8-week p-value 
Lateral Gastrocnemius 
Type I (mean CSA µm2) 1333.5 ± 249.4 1232.6 ± 431.9 1454.0 ± 334.6 0.917 
Type IIa (mean CSA µm2) 1416.9 ± 142.2 1278.0 ± 229.2 1530.7 ± 229.22 0.740 
Type IIb (mean CSA µm2) 3026.7 ± 239.8 2218.1 ± 428.95 2467.6 ± 391.6 0.205 
Type IIx (mean CSA µm2) 2211.7 ± 231.1 1906.3 ± 386.7 1771.9 ± 353.0 0.545 
Mid-Gastrocnemius; VML border 
Type I (mean CSA µm2) 1099.1 ± 163.4 680.6 ± 346.6 1009.5 ± 219.2 0.564 
Type IIa (mean CSA µm2) 1289.0 ± 148.7 1138.4 ± 284.7 1563.3 ± 186.4 0.383 
Type IIb (mean CSA µm2) 2977.7 ± 238.3 1792.7 ± 426.3 2595.0 ± 360.3 0.070 
Type IIx (mean CSA µm2) 1777.9 ± 179.7 1268.7 ± 311.3 1976.9 ± 235.3 0.213 
Medial Gastrocnemius 
Type I (mean CSA µm2) 834.7 ± 175.0 846.1 ± 234.7 1150 ± 234.7 0.535 
Type IIa (mean CSA µm2) 1241.6 ± 104.1 1104.1 ± 180.3 1165.6 ± 164.5 0.787 
Type IIb (mean CSA µm2) 2746.3 ± 219.5 2393.5 ± 392.6 2128.7 ± 331.8 0.296 
Type IIx (mean CSA µm2) 1597.4 ± 188.7 1641.4 ± 337.6 1791.3 ± 308.2 0.867 
Data analyzed by one-way ANOVA, presented as mean ± SD. Different than *control 
 
a main effect of group was observed when analyzing cross-sectional area of type 
I, IIa, IIb, and IIx fibers across the whole muscle, where smaller cross-sectional 
areas were observed 4-weeks and 8-weeks post-VML compared to controls  
Table 6. Fiber type specific composition of gastrocnemius muscle following VML 
 Control VML 4-week VML 8-week p-value 
Lateral Gastrocnemius 
Percent of Type I Fibers 3.9 ± 1.9 9.1 ± 3.5 15.8 ± 3.2 * 0.012 
Percent of Type IIa Fibers 20.4 ± 4.0 37.7 ± 7.1 32.6 ± 6.5 0.078 
Percent of Type IIb Fibers 60.4 ± 6.5 35.8 ± 11.7 36.9 ± 10.6 0.083 
Percent of Type IIx Fibers 15.2 ± 2.5 17.4 ± 4.4 14.7 ± 4.0 0.888 
Mid-Gastrocnemius; VML border 
Percent of Type I Fibers 7.2 ± 3.5 15.7 ± 6.3 6.1 ± 5.3 0.451 
Percent of Type IIa Fibers 19.2 ± 4.3 22.8 ± 7.7 26.5 ± 6.5 0.640 
Percent of Type IIb Fibers 59.7 ± 7.6 54.7 ± 13.7 50.0 ± 11.5 0.777 
Percent of Type IIx Fibers 13.9 ± 2.6 6.8 ± 4.7 17.4 ± 4.0 0.234 
Medial Gastrocnemius 
Percent of Type I Fibers 3.9 ± 2.3 19.1 ± 4.1 * 13.4 ± 3.4 0.006 
Percent of Type IIa Fibers 20.6 ± 3.4 39.5 ± 6.1 * 22.9 ± 5.2 0.039 
Percent of Type IIb Fibers 59.0 ± 22.9 22.8 ± 10.1 * 50.7 ± 8.5 0.016 
Percent of Type IIx Fibers 16.6 ± 2.3 18.6 ± 4.2 13.0 ± 3.6 0.574 




(p<0.001). A main effect of fiber type was also observed, whereby type IIb fibers 
were larger than type I, IIa, and IIx fibers, and type IIx fibers were larger than type 
I and IIa fibers (all p<0.001; Figure 6B). When mean proportions were compared, 
there was a significant interaction between group and fiber type (p<0.001), where 
 
Figure 6: Fiber type specific differences in the gastrocnemius muscles were evaluated up to 8-
weeks following VML. A) The distribution of muscle fiber cross-sectional area (CSA) in controls 
was normally distributed at 1,000-1,500µm² with a slight right skew. Compared to control, the 
distribution of muscle fiber cross-sectional area shifted left at 4- and 8-weeks post VML 
(p<0.001), but VML groups were not different than each other (p<0.017). B) Overall muscle fiber 
CSA was smaller at 4-weeks post-VML compared to control (main effect experimental group; 
p=0.011). As expected, type IIb fibers had a greater CSA than type I, IIa, and IIx; additionally 
type IIx fibers were larger than type I and IIa fibers (main effect of fiber type; p<0.001). C) There 
was a significant interaction (group x fiber type; p=0.001) in the proportion of fiber types across 
the gastrocnemius muscle. Specifically muscles post-VML had a higher proportion of type IIb 
fibers compared to type I and IIx at 4-weeks, and type I, IIa, and IIx at 8-weeks; and control 
muscles generally demonstrated a greater proportion of type IIb fibers compared to type I, IIa, 
and IIx, and compared to type IIb fibers of muscles 4-weeks post-VML. Data presented as 
mean±SD; analyzed by chi-squared and two-way ANOVA, significant main effects are indicated 
within figure. Within experimental group, significantly different from *type IIb; †type IIa. Within fiber 




type I, IIx, and IIa were the least represented, and type IIb was the most 
represented. Compared to control, VML groups tended to have greater expression 
of type I and IIa fibers, and lower type IIb, particularly at 4 weeks (Figure 6C). 
Interestingly, muscle fiber type proportions were not significantly different within 
the mid-region bordering the VML injury (p≥0.234). In contrast, at 4-weeks post-
VML, the proportion of type I and IIa muscle fibers increased substantially while 
the proportion of type IIb fibers decreased in the medial gastrocnemius (p≤0.039; 
Table 6). By 8-weeks post-VML, regional differences in fiber type proportion 




The pathophysiologic comorbidities of VML injury are vast and range from 
functional deficits, impaired inflammatory signaling, and chronic fibrotic deposition. 
However, to date both muscle-specific and whole-body understanding of the 
metabolic consequences of VML injury are incompletely understood, in both 
animal models and the patient population. The primary finding in this work is that 
even with a relatively small volume of the total body skeletal muscle lost to VML 
injury, there are local and whole-body impairments to metabolism. Whole-body 
metabolism alterations seem to be largely due to changes in carbohydrate 
utilization that occur during active hours, rather than reductions in physical activity 
overall. 
Following VML injury, less carbohydrates and more lipids were utilized per unit 
of physical activity. This finding may indicate metabolic inflexibility, which is the 
inability to transition effectively between carbohydrate and lipid utilization [125]. 
Metabolic inflexibility, precedes various disorders, placing the organism at greater 
risk for comorbidities. Sedentarism often occurs following orthopaedic injury [83–
85], which in turn, increases the risk of metabolic inflexibility and additional 
comorbidities such as obesity, type II diabetes, heart disease, and osteoporosis 




may not decrease following VML injury, yet herein, metabolic impairment still 
occurred. This supports that mitochondrial dysfunction in VML-injured muscle may 
drive whole body metabolic impairment as a primary outcome of VML injury, a 
previously unreported finding with significant comorbidity implications.  
Following VML injury, physical activity was not reduced despite a substantial 
loss of force generating capacity. The force loss associated with VML injury is 
primarily due to an indiscriminate loss of contractile tissue in addition to a one of 
many secondary losses due to axotomy, as observed previously in VML injury 
[102]. Axotomy indicates denervation, which has been shown to increase 
representation of slow muscle fibers and decrease representation of fast fibers 
across the muscle in a denervation specific model [64]. A similar shift in fiber type 
was observed acutely within this study, supporting that some of the fiber type 
changes observed post-VML may be caused by axotomy. A shift to slower fiber 
type across the muscle may signify a preference to preserve low force function, 
such as ambulation, while sacrificing maximal force generation. Limiting force may 
serve to protect the muscle from damaging, high-force contractions during the 
early wound healing phase. However, impairments to force generation persisted 
chronically and there appeared to be little or no overall improvement to oxidative 
function despite an apparent preference to conserve oxidative muscle fibers. 
Although oxidative muscle fibers were conserved, the oxidative potential of the 
muscle was not improved, as evidenced by a decrease in capillarity and no change 
in most measures of mitochondrial enzyme activity and content. An increase 
inmetabolic activity, as evidenced by an increase in NADH expression was 
observed, but may indicate mitochondrial dysregulation rather than positive 
adaptation. An increase in mitochondrial activity without an improvement in 
contractile or metabolic function may indicate that mitochondrial function is 
impaired following VML. . It is likely that mitochondrial dysregulation underlies 
pathologic outcomes following VML injury, a concept that is corroborated by 
previous work. Specifically, mitochondrial dysregulation occurs post VML injury, 




compared to uninjured muscle [98,107,116]. Mitochondrial dysregulation also 
occurs in other conditions besides VML, including denervation [66,67], burn [60], 
and immobilization [90]. Normally, metabolic outcomes improve over time once 
regeneration, mobilization, and rehabilitation occur. In contrast, mobilization and 
rehabilitation following VML injury is not sufficient to attenuate metabolic 
impairment [126], and regeneration is currently not possible. 
Failure in regenerative mechanisms is of primary concern in VML injury and 
complicates therapeutic efforts post-injury. Within this study, the acute and chronic 
increase in centrally located nuclei support that the intramuscular environment is 
unstable long past the time of injury. It is likely that early wound healing processes, 
such as fibrotic deposition [106,127,128] are prioritized, impairing the capacity of 
the muscle to adapt positively to physical activity or rehabilitation. Compounding 
this, the acute decline in capillary distribution indicates that the muscular 
environment may have lower blood supply, which may inhibit beneficial adaptation 
and functional capacity. Capillarity did not return to normal until 8-weeks post-
injury, which also aligns with a return to pre-injury levels of complex I activity, fiber 
type proportion, and size distribution. For conditions like burn [63], critical illness 
[129], and traumatic injury [130] early mobilization is recommended and generally 
improves outcomes. However, in cases of VML injury the underlying 
pathophysiology may resist the benefits of early rehabilitation, necessitating further 
attention to address metabolic impairment early chronically in treatment. 
In conclusion, metabolic inflexibility occurred following VML injury as a primary 
outcome, largely due to reductions in carbohydrate utilization at the whole-body 
level. Though it was hypothesized that reductions in physical activity would drive 
metabolic impairment, the pathophysiology of VML injury was sufficient to cause 
metabolic inflexibility without a change in physical activity. This finding may 
indicate a need to treat metabolic disorder, as even if recommended levels of 
physical activity are met, metabolic impairment may still occur, increasing the risk 
for metabolic comorbidity. Further assessment of the muscle remaining after injury 




oxidative fibers. The slowing of the muscle may be protective, preventing 
damaging force generation during wound healing, however force loss persists in 
VML, leaving the injured limb disabled chronically. Additionally, it is possible that 
reduced capillary support contributes to poor functional outcomes post-injury by 
limiting perfusion to the site of injury. In sum, regenerative and rehabilitative 
strategies will need to address functional and metabolic pathophysiologic changes 
early post injury, and failure to do so may increase the risk for whole body 










The findings from this work provide a novel insight into the complex inner 
workings of the pathophysiology of VML injury and how it affects the organism as 
a whole. Following VML injury, the loss of contractile tissue impairs force 
generation of the effected muscle. In some regards, limiting force generation may 
be protective during the early stages of wound healing, both preventing excessive 
force generation and preserving low force function. However, force loss is not 
recoverable in VML injury, impairing the overall function of the affected limb. 
Alongside loss of force, intramuscular metabolism appears to shift towards an 
oxidative preference, maintaining oxidative fibers while losing glycolytic. This 
relationship is also observed following denervation [64], and may support that 
some of the pathophysiologic outcomes of VML injury may be directly caused by 
motor neuron axotomy, which has been observed in VML injury [102]. 
Despite a shift towards oxidative fibers, whole body oxidative function actually 
decreased over time, as evidenced by a whole-body reduction in metabolic rate 
and RER. Metabolic impairment may be explained in part by dysfunction in skeletal 
muscle specific mitochondria, which has been observed in various muscle injuries, 
including denervation [67] and burn [60], as well as in VML injury [98]. While the 
exact link between VML injury and whole-body metabolic impairment is not yet 
clear, it is possible that damage to the muscle and surrounding structures may 
cause an effect systemically. Damage to the mitochondrial and capillary networks 
in VML injury may allow release of mitochondrial fragments into circulation, which 
may increase inflammatory signaling [95]. Inflammation has been linked to 
metabolic impairments in various diseases and conditions, including muscular 
dystrophy and critical illness. Though different in etiology than VML, muscular 
dystrophy may have some similarities that help to explain some of the whole-body 
metabolic dysfunction post-VML injury. In muscular dystrophy, impairments to the 
muscle membrane results in atrophy and fibrosis, leading to cycles of degeneration 
and regeneration, increases in centrally located nuclei, and systemic inflammation 
[78,79]. Similarly, atrophy and fibrosis occur post-VML, along with increases in 




occurs after VML injury, resulting in blunted glucose metabolism. Further work will 
need to elucidate if inflammation is the link between VML-injury and whole-body 
metabolic impairment, and treatment may need to address pathophysiologic 
changes to the muscle alongside of treatment at the whole-body level. 
VML injury presents a unique and difficult challenge to regenerative and 
rehabilitative approaches. Ideally, regeneration of the lost muscle following VML 
injury would improve both function of the limb and mitigate whole body metabolic 
disorder. However, no regenerative treatment to date has been able to induce 
substantial de novo muscle fiber regeneration post-VML, nor has any rehabilitative 
method been able to fully restore force loss [100,115,126]. As regeneration is 
currently unobtainable, improving the remaining muscle plasticity may be a viable 
option to improve both acute and chronic outcomes post-VML. Reduced plasticity 
of the injured muscle is a known barrier to both regenerative and rehabilitative 
efforts [126], therefore, reinstating muscle responsiveness will be a critical aspect 
of treatment efforts. This may prove especially important as the patient ages, as 
age related declines to muscle and mitochondria may worsen outcomes long-term. 
Translational research has had some success with restoring plasticity to VML 
injured muscle through PGC-1α overexpression [98], but it is unknown if such an 
improvement can prevent whole-body metabolic impairment. Additionally, 
transgenic overexpression of PGC-1α is not viable for human treatment, therefore 
using other mitochondrial therapies may be necessary. For example, 
pyrroloquinoline quinone has been utilized to improve mitochondrial function 
following denervation [64], but it is unknown if similar effects may occur in humans 
or following VML injury. 
Some rehabilitative benefits have been observed following VML injury 
[108,116], however the effects are very limited when compared to uninjured 
muscle. There is a possibility that restoring muscle plasticity in combination with 
rehabilitation may be able to augment outcomes further than either paradigm 
alone, allowing improvements in metabolic function. However more work will need 




is unlikely that even a combination of therapies will be successful in fully 
overcoming the overwhelming pathology presented by VML injury. As future work 
aims towards solving VML, consideration for chronic care needs to be taken 
seriously as relatively small loses in muscle tissue may have the potential to impair 
metabolic outcomes on the full body level, even if physical activity is maintained, 
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